4th Quarter - Report

AKIN GUMP STRAUSS HAUER & FELD for OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

The Innovation Act (H.R. 9); Helping Families in Mental Health Crisis Act (H.R. 2646); Mental Health Reform Act of 2015 (H.R. 1945); Mental Health Awareness and Improvement Act (S. 1893).

LobbyistCovered position, as disclosed
HEIDE BAJNRAUH —
JOHN JONAS —
RICHARD THOMPSON —
ELI TOMAR —
MATTHEW TODD TUTEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2646 (115th), S. 1893 (115th), H.R. 9 (115th), H.R. 1945 (115th)

Health Issues HCR

H.R. 2646, the Helping Families in Mental Health Crisis Act; H.R. 2690, Strengthening Mental Health In Our Communities Act; H.R. 6, 21st Century Cures initiative; S. 481, Improving Regulatory Transparency for New Medical Therapies Act

LobbyistCovered position, as disclosed
LOUIS AGNELLO —
HEIDE BAJNRAUH —
JOHN JONAS —
RICHARD THOMPSON —
MATTHEW TODD TUTEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 481 (115th), H.R. 6 (115th), H.R. 2646 (115th), H.R. 2690 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.